News Appetite suppressant semaglutide is to be made available to treat obesity in England BMJ 2023; 380 doi: https://doi.org/10.1136/bmj.p556 (Published 08 March 2023) Cite this as: BMJ 2023;380:p556 Article Related content Metrics Responses Peer review Related articles News NICE recommends weight loss drug semaglutide for obese adults Published: 08 February 2022; BMJ 376 doi:10.1136/bmj.o340 News Obesity: Politicians’ fears over “nanny-statism” have contributed to failed strategies, says report Published: 20 April 2023; BMJ 381 doi:10.1136/bmj.p900 News Sixty seconds on . . . the cost of semaglutide Published: 31 August 2023; BMJ 382 doi:10.1136/bmj.p2009 See more MPs back proposals to legalise assisted dying in England and Wales BMJ November 29, 2024, 387 q2691; DOI: https://doi.org/10.1136/bmj.q2691 Mpox: UK reports new case of clade Ib infection BMJ November 29, 2024, 387 q2687; DOI: https://doi.org/10.1136/bmj.q2687 Asthma: New UK guidelines signal “step change” in diagnosis and treatment BMJ November 29, 2024, 387 q2685; DOI: https://doi.org/10.1136/bmj.q2685 Gambling: Statutory levy on betting companies will raise £100m for services and research from next April BMJ November 28, 2024, 387 q2667; DOI: https://doi.org/10.1136/bmj.q2667 David Oliver: The current stand-off may leave physician associates stranded BMJ November 27, 2024, 387 q2613; DOI: https://doi.org/10.1136/bmj.q2613 Cited by... Sixty seconds on . . . the cost of semaglutideFulltext PDF Obesity: Politicians fears over "nanny-statism" have contributed to failed strategies, says reportFulltext PDF
